After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
DHR belongs to the Healthcare sector of the NYSE while operating in the Diagnostics & Research industry. The current market capitalization of Danaher Corp is $147.17B. A total of 5.65 million shares were traded on the day, compared to an average of 4.17M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, DHR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, King William bought 114,351 shares of DHR for 209.97 per share on Feb 21 ’25. In a previous transaction on Feb 18 ’25, Sabeti Pardis C bought 4,337 shares at 204.28 per share.
Among the insiders who sold shares, SPOON ALAN G disposed of 550 shares on Feb 07 ’25 at a per-share price of $206.46. This resulted in the Director holding 120,518 shares of DHR after the transaction. In another insider transaction, SPOON ALAN G bought 550 shares at $206.46 per share on Feb 07 ’25.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Danaher Corp pays an annual dividend of $1.08, resulting in a dividend yield of 0.52%, and it has a price to earnings (P/E) ratio of 38.94. DHR’s most recent ex-dividend date was 0.62% when it declared a $0.32 quarterly dividend that was paid in cash on 3/28/2025. Previously, the company paid the dividend on 12/27/2024 with an ex-dividend date of 0.46%. The DHR stock dividend was $0.27 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for DHR in the last 3 months, the mean price target is $266.61 with high estimates of $310.00 and low estimates of $240.00. In terms of 52-week highs and lows, DHR has a high of $281.70 and a low of $196.80.
As of this writing, DHR has an earnings estimate of $1.64 per share for the current quarter. EPS was calculated based on a consensus of 23.0 estimates, with a high estimate of $1.97 per share and a lower estimate of $1.56.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. DHR’s latest balance sheet shows that the firm has $2.59B in Cash & Short Term Investments as of fiscal 2021. There were $23.27B in debt and $8.14B in liabilities at the time. Its Book Value Per Share was $68.90, while its Total Shareholder’s Equity was $45.18B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DHR is Buy with a score of 4.46.
